Matthew Greenblatt, MD, PhD, Receives 2025 Paul-Gallin Trailblazer Prize for Physician-Scientists from FNIH

Written by Emily J. Thompson, Senior Investment Analyst

Source: Businesswire

Updated: Aug 21 2025

0mins

Source: Businesswire

Award Announcement: Dr. Matthew Greenblatt from Weill Cornell Medicine has been awarded the 2025 Paul-Gallin Trailblazer Prize for his groundbreaking research on distinct stem cell types involved in bone formation.
Research Impact: His discoveries have significant implications for treating osteoporosis, rare genetic bone disorders, and cancer metastases, reshaping the understanding of bone development.
Recognition of Physician-Scientists: The award highlights the essential role of physician-scientists in translating basic scientific discoveries into practical therapies for patients.
Upcoming Events: Dr. Greenblatt will receive the award at the FNIH Annual Awards Ceremony on October 22, 2025, and will present his research at the 2026 AAP/ASCI/APSA Joint Meeting in Chicago.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Matthew Greenblatt, MD, PhD, Receives 2025 Paul-Gallin Trailblazer Prize for Physician-Scientists from FNIH

About the author

Top News

Ford Announces $19.5B EV Restructuring Charges

Fed Cuts Interest Rates Amid Economic Concerns

SpaceX Targets $800 Billion Valuation in Secondary Sale

U.S. Consumer Sentiment Slightly Improves in December

Related Articles

OptimizeRx Expands NPI Reach by 37% with Four New Partner Agreements

AZIO AI Completes $480 Million Independent Valuation, Accelerates Strategic Transactions

People Also Watch